T-Cell/Histiocyte-Rich Large B-Cell Lymphoma of the Thyroid

Experimental Hematology & Oncology

Hideo Harigae¹  Ryo Ichinohasama³  Jun Kimura²  Kei Saito⁴  Yasuaki Watanabe⁴  Satoshi Ichikawa¹ 

[1] Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan;Department of Hematology, Yamagata City Hospital Saiseikan, 1-3-26 Nanukamachi, Yamagata, 990-8533, Japan;Department of Hematopathology, Tohoku University Graduate School of Medicine, Sendai, Japan;Clinical Training Center, Yamagata City Hospital Saiseikan, Yamagata, Japan

关键词: R-CHOP;    Thyroid lymphoma;    T-cell/histiocyte-rich large B-cell lymphoma;   

Others  :  813921
DOI  :  10.1186/2162-3619-2-1

 received in 2012-11-25, accepted in 2013-01-05,  发布年份 2013

【 摘 要 】

T-cell/histiocyte-rich large B-cell lymphoma (THRLBCL) is a rare subtype of diffuse large B-cell lymphoma, and has been reported to mainly affect lymph nodes with advanced Ann Arbor stage. We present a 69-year-old woman with a past history of chronic thyroiditis, who had suffered from rapidly-growing thyroid tumor. No other lymph nodes swelling or extranodal lesions were detected. She promptly underwent surgery with resection of the thyroid tumor, and the diagnosis of THRLBCL was established pathologically. She was successfully treated by standard rituximab-containing chemotherapy. To our knowledge, this is the first case report of THRLBCL exclusively arising in the thyroid.

【 授权许可】

   
2013 Ichikawa et al.;

【 图 表 】

Figure 1.

【 参考文献 】

• [1]De Wolf-Peeters C, Delabie J, Campo E, Jaffe ES, Delsol G, et al.: T-cell/histiocyte-rich large B-cell lymphoma. In WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th edition. Edited by Swedlow SH. Lyon, France: International Agency for Research on Cancer; 2008:238-239.
• [2]Weshi AE, Akhtar S, Mourad WA, Ajarim D, Abdelsalm M, Khafaga Y, et al.: T-cell/histiocyte-rich B-cell lymphoma: Clinical presentation, management and prognostic factors: report on 61 patients and review of literature. Leuk Lymphoma 2007, 48:1764-1773.
• [3]Bouadallar R, Mounier N, Guettier C, Molina T, Ribrag V, Thieblemont C, et al.: T-cell/histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: a matched-control analysis. J Clin Oncol 2003, 21:1271-1277.
• [4]Gregory A, Thompson LDR, Frommelt RA, Bijwaard KE, Heffess CS, Abbondanzo SL: Malignant Lymphoma of the Thyroid Gland; A Clinicopathologic Study of 108 Cases. Am J Surg Pathol 2000, 24:623-639.
• [5]Mishima Y, Terui Y, Yokoyama M, Nishimura N, Sakajiri A, Ueda K, et al.: R-CHOP with dose-attenuated radiation therapy could induce good prognosis in gastric diffuse large B cell lymphoma. Exp Hematol Oncol 2012, 1:30. BioMed Central Full Text